| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |